Company intelligence / Profile preview

Seneca Gaming

Wayne, PA, USA

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Seneca Therapeutics is a clinical-stage biopharmaceutical company focused on developing oncolytic virus therapies for the treatment of solid tumors. The company's lead candidate, SVV-001 (Seneca Valley Virus), is a naturally occurring oncolytic virus that selectively targets and kills cancer cells expressing the TEM8 (ANTXR1) receptor. Seneca Therapeutics is advancing SVV-001 both as a monotherapy and in combination with immune checkpoint inhibitors to enhance anti-tumor immune responses. The company aims to leverage the unique properties of SVV-001 to treat a wide range of cancers, including neuroendocrine and pediatric tumors.

Therapeutic areas: Oncology
Modalities: Oncolytic virus therapyViral therapyImmunotherapy
Industry: Biotech

Partnerships

University of MiamiMayo Clinic

Beyond the preview

Go deeper on Seneca Gaming.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seneca Gaming.

Explore the full profile